A 2-Part, Randomized, Double-Blind, Safety and Tolerability Study Evaluating KNS-760704 in Patients With Amyotrophic Lateral Sclerosis (ALS).
Phase of Trial: Phase II
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions
- Sponsors Knopp Biosciences; Knopp Neurosciences
- 07 Jun 2017 Biomarkers information updated
- 10 Mar 2017 According to a Knopp Biosciences media release, results were published in the journal Blood Cells, Molecules and Diseases.
- 07 Mar 2017 Results published in the Knopp Biosciences media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History